MorphoSys AG — Company Overview, News & Financial Data

MorphoSys (ETR:MOR), (NASDAQ:MOR) is a biotechnology company focused on the development of innovative antibody therapies for the treatment of cancer and autoimmune diseases. It is traded on the NASDAQ stock exchange under the ticker code NASDAQ:MOR. The company leverages its proprietary technology platforms to design and develop monoclonal antibodies, aiming to bring novel treatments to patients who have limited treatment options. MorphoSys has a diverse pipeline of therapeutic candidates in various stages of clinical development, alongside strategic partnerships with leading pharmaceutical companies to advance and commercialize its therapies. The company's objectives include advancing its research and development capabilities, expanding its product pipeline, and achieving global commercial success with its innovative therapeutic solutions.